Health News Releases

July 21, 2021 10:55

Crown Bioscience Invests in Commercial Leadership

Crown Bioscience, a JSR Life Sciences company, today announces the appointment of Alex Slater as Vice President of Business Development, North America and Europe. In this role, Mr Slater will be respo

July 20, 2021 11:40

Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange

Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) (NYSE:TAK) today announced that it has filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the

July 20, 2021 10:25

New Zealand Aviation Security Service to introduce UV light tray disinfection with Smiths Detection

Smiths Detection today announced with New Zealand Aviation Security Service (AvSec) that it has completed deployment of 18 units of its new Ultraviolet (UV) light tray disinfection kit to help enhance

July 19, 2021 10:30

ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs

For media and investors only ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today presented

July 19, 2021 09:45

Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering

Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese

July 16, 2021 09:54

SENSCO to Enter Global Market with Its Patented Thread Lifting ‘TIMEMACHINE LIFT ANCHORING DUAL COG’

SENSCO, a Korean professional medical device Thread Lift manufacturing company, said that its thread lifting, TIMEMACHINE LIFT ANCHORING DUAL COG is effective in improving skin elasticity and removing

July 15, 2021 10:20

NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic

NEC Corporation (NEC; TOKYO: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC developed a new

July 14, 2021 13:15

iNova Pharmaceuticals Earns the Best Place To Work Global Certification

iNova Pharmaceuticals, a company that markets and distributes a wide range of over-the-counter and prescription medicines in Australasia, Asia and Africa, has recently been recognised as one of the be

July 13, 2021 09:45

Theramex Appoints Sigurd Kirk to the Board of Directors

Theramex, a CVC Capital Partners (“CVC”) portfolio company focused on Women’s Health has announced that Sigurd (Sig) Kirk has been appointed as a member of the Board of Directors for Theramex. Therame

July 13, 2021 09:13

AI in Diagnostic Imaging Market Registers Growth as Healthcare Sector Exhibits Demand for More Precise and Definitive Diagnosis: Fact MR Study

The Asia Pacific market for artificial intelligence (AI) in diagnostic imaging is likely to grow at an impressive pace through 2021. Fact MR, a leading market research and competitive intelligence pro

July 12, 2021 11:10

Reversal of Aging of Human Cartilage, Restoring Youthfulness; the First of Its Kind Feat by Edogawa Hospital, Japan.

Cartilage of the knee joint, when severely damaged by age related wear and tear or injury or osteoarthritis, which is removed and usually discarded, during joint replacement surgery, now could be reju

July 12, 2021 09:45

New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from two final analyses from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-lab

July 09, 2021 10:20

Kyalio Launches Day-to-Day Endo-Laparoscopic VR Surgical Library, the First in Asia

On July 1st, 2021, Kyalio and the Endoscopic and Laparoscopic Surgeons of Asia (ELSA), a leading surgical association with over 2,600 members, jointly launched the Day-to-Day Endo-Laparoscopic Virtual

July 08, 2021 11:40

New Survey by Patient Safety Movement Foundation Reveals Only Forty-Five Percent of Patients Feel in Control of Their Health

The COVID-19 pandemic took the world by storm in 2020 and drew attention to healthcare performance, access and resource use. Unfortunately, it took the impact of something as monumental as a worldwide

July 07, 2021 14:00

Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)

Alvotech, the Iceland-based biosimilar company, today announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvo

July 07, 2021 11:25

Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction

The EMPEROR-Preserved Phase III trial met its primary endpoint, establishing empagliflozin as the first and only therapy to significantly reduce the risk of the composite of cardiovascular death or ho

July 07, 2021 10:30

New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients

Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Critical Care in which Dr. Tae Youn Kim and colleagues at the Dongguk University College of Medicine and Yonse

July 06, 2021 20:00

Allurion Technologies Unveils Transformed Allurion™ Weight Loss Program and New Corporate Brand

Allurion Technologies announced today two major milestones with the launch of the transformed Allurion Weight Loss Program and new worldwide brand for the company and its program. Allurion began co

July 02, 2021 16:10

Sentrx™ Animal Care, Inc. Announces Manufacturing Facility Expansion to Accommodate Accelerated Growth

On May 20th, 2021 Sentrx Animal Care held a ribbon cutting ceremony to celebrate the completion and opening of its brand new 22,000 square foot manufacturing facility in Salt Lake City, Utah. The expa

July 02, 2021 11:50

LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients

LG Chem announced topline results for the phase 2 study evaluating the efficacy and safety profiles of LC350189, a novel non-purine xanthine oxidase inhibitor for the chronic management of hyperuricem

July 02, 2021 11:10

Ferring Pharmaceuticals Announces Changes to Board of Directors

Ferring Pharmaceuticals announced today that Frederik Paulsen is stepping down from his role as Chairman of the Board of Directors[*] and transitioning to the role of Honorary Chairman. Lars Rebien Sø

July 02, 2021 10:50

Convert Group Study: COVID-19 Drew More Than 2.7 Billion Visits to Global ePharmacies in 96 Countries in Q1'21

Consumers and patients globally have turned to digital platforms to purchase their prescription (Rx), non-prescription (OTC) medication and parapharmacy products with more than 2.7 billion online visi

July 01, 2021 15:50

SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution

SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The par

July 01, 2021 14:00

Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan

Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) today announced submission of a New Drug Application (NDA) for its new anti-cancer d

June 30, 2021 11:50

Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 (the “Annual Report”) wit

News by Region

News by Industry